Hemp Health Spolka Akcyjna Logo

Hemp Health Spolka Akcyjna

A vertically integrated supplier of medical cannabis raw material for the Polish market.

HMP | WAR

Overview

Corporate Details

ISIN(s):
PLEBCSL00011 (+4 more)
LEI:
259400HT196UIMTSG008
Country:
Poland
Address:
WARSZAWA JANA STYKI 23, 03-928 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hemp & Health S.A. is a company operating at the intersection of the hemp and health sectors. The company's 2024-2025 strategy is centered on creating and managing a vertically integrated supply chain for medical marijuana. Its planned operations span from proprietary cultivation, importation, and processing to the final distribution of medical cannabis as a pharmaceutical raw material. The company's primary strategic objective is to establish itself as a leading Polish entity in the medical cannabis market, controlling the entire value chain to ensure quality and supply.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Hemp Health Spolka Akcyjna and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-10 10:55
M&A Activity
Rozpoczęcie negocjacji dotyczących nabycia przez Hemp_Health spółki z branży ma…
Polish 1.2 KB
2024-04-30 13:22
Share Issue/Capital Change
Przydział warrantów subskrypcyjnych serii B - Content (PL)
Polish 831 bytes
2024-04-23 20:47
M&A Activity
Zakończenie negocjacji opisanych w raporcie ESPI nr 5/2024 bez uzyskania porozu…
Polish 845 bytes
2024-04-22 12:22
Major Shareholding Notification
zal01_DC.22.04.2024.FormularzA.pdf
Polish 49.4 KB
2024-04-22 12:22
Major Shareholding Notification
Zmiana stanu posiadania - Content (PL)
Polish 562 bytes
2024-04-15 09:35
Legal Proceedings Report
Złożenie wniosku na import surowca farmaceutycznego przez spółkę stowarzyszoną …
Polish 1.4 KB
2024-03-28 08:33
M&A Activity
Zwrot pożyczonych akcji Cannabis Poland S.A. - Content (PL)
Polish 761 bytes
2024-03-20 21:48
Share Issue/Capital Change
Podwyższenie kapitału zakładowego spółki zależnej w wyniku nowej emisji akcji -…
Polish 707 bytes
2024-02-22 11:36
Share Issue/Capital Change
Zawarcie umowy inwestycyjnej w związku z istotnym dokapitalizowaniem spółki Hem…
Polish 2.4 KB
2024-02-21 12:29
M&A Activity
Podpisanie Term Sheet dotyczącego nabycia plantacji marihuany medycznej przez H…
Polish 1.9 KB
2024-02-12 13:16
Regulatory News Service
Podpisanie Term Sheet z portugalskim zakładem farmaceutycznym przez spółkę stow…
Polish 2.3 KB
2024-02-09 11:35
Regulatory News Service
Otrzymanie zezwolenia na prowadzenie obrotu hurtowego środkami odurzającymi ora…
Polish 1.4 KB
2024-01-22 08:42
M&A Activity
Zawarcie listu intencyjnego dotyczącego przeprowadzenia negocjacji dotyczących …
Polish 1.3 KB
2024-01-15 16:20
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 934 bytes
2023-12-19 16:35
Proxy Solicitation & Information Statement
zal03_H_H-NWZ-15.01.24-formularz_pelnomocnictwa.pdf
Polish 164.4 KB

Automate Your Workflow. Get a real-time feed of all Hemp Health Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hemp Health Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.